The purification and characterization of alpha interferons and related cytokine receptors-A personal account

Cytokine and Growth Factor Reviews

Volumn 18, Issue 5-6, 2007, Pages 519-524

  Rubinstein, Menachem ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

IFN; IFNAR2; IL 18BP; RP HPLC; sLDLR; TNF

Indexed keywords

ALPHA INTERFERON; BINDING PROTEIN; CYTOKINE RECEPTOR; INTERFERON; INTERLEUKIN 18; RECOMBINANT ALPHA2A INTERFERON; TUMOR NECROSIS FACTOR;

ARTICLE; HAIRY CELL LEUKEMIA; HEPATITIS C; HUMAN; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEIN PURIFICATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; INTERFERON-ALPHA; RECEPTORS, CYTOKINE;

HEPATITIS C VIRUS;

EID: 34548119866     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2007.06.011     Document Type: Article

References (23)

1. Udenfriend S., Stein S., Bohlen P., Dairman W., Leimgruber W., and Weigele M. Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range. Science 178 (1972) 871-872
2. Bohlen P., Stein S., Dairman W., and Udenfriend S. Fluorometric assay of proteins in the nanogram range. Arch Biochem Biophys 155 (1973) 213-220
3. Stein S., Bohlen P., Stone J., Dairman W., and Udenfriend S. Amino acid analysis with fluorescamine at the picomole level. Arch Biochem Biophys 155 (1973) 202-212
4. Rubinstein M., Stein S., Gerber L.D., and Udenfriend S. Isolation and characterization of the opioid peptides from rat pituitary: beta-lipotropin. Proc Natl Acad Sci USA 74 (1977) 3052-3055
5. Rubinstein M., Stein S., and Udenfriend S. Isolation and characterization of the opioid peptides from rat pituitary: beta-endorphin. Proc Natl Acad Sci USA 74 (1977) 4969-4972
6. Rubinstein M., Rubinstein S., Familletti P.C., Gross M.S., Miller R.S., Waldman A.A., et al. Human leukocyte interferon purified to homogeneity. Science 202 (1978) 1289-1290
7. Rubinstein M., Stein S., and Udenfriend S. Characterization of pro-opiocortin, a precursor to opioid peptides and corticotropin. Proc Natl Acad Sci USA 75 (1978) 669-671
8. Isaacs A., and Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B: Biol Sci 147 (1957) 258-267
9. Rubinstein S., Familletti P.C., and Pestka S. Convenient assay for interferons. J Virol 37 (1981) 755-758
10. Pestka S, Rubinstein M. Protein purification process and product. US Patent 1985, 4,503,035.
11. Rubinstein M., Rubinstein S., Familletti P.C., Miller R.S., Waldman A.A., and Pestka S. Human leukocyte interferon: production, purification to homogeneity, and initial characterization. Proc Natl Acad Sci USA 76 (1979) 640-644
12. Rubinstein M., Levy W.P., Moschera J.A., Lai C.Y., Hershberg R.D., Bartlett R., et al. Human leukocyte interferon: isolation and characterization of several molecular forms. Arch Biochem Biophys 210 (1981) 307-318
13. Rubinstein M. Preparative high-performance liquid partition chromatography of proteins. Anal Biochem 98 (1979) 1-7
14. Levy W.P., Shively J., Rubinstein M., Del Valle U., and Pestka S. Amino-terminal amino acid sequence of human leukocyte interferon. Proc Natl Acad Sci USA 77 (1980) 5102-5104
15. Nagata S., Taira H., Hall A., Johnsrud L., Streuli M., Ecsödi J., et al. Synthesis in E. coli of a polypeptide with human leukocyte interferon activity. Nature 284 (1980) 316-320
16. Engelmann H., Aderka D., Rubinstein M., Rotman D., and Wallach D. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem 264 (1989) 11974-11980
17. Wallach D, Engelmann H, Aderka D, Novick D, Rubinstein M. Tumor necrosis factor binding protein II, its purification and antibodies thereto. European Patent 1990, 0,398,327.
18. Novick D., Engelmann H., Wallach D., and Rubinstein M. Soluble cytokine receptors are present in normal human urine. J Exp Med 170 (1989) 1409-1414
19. Novick D., Cohen B., and Rubinstein M. Soluble interferon-alpha receptor molecules are present in body fluids. FEBS Lett 314 (1992) 445-448
20. Fischer D.G., Tal N., Novick D., Barak S., and Rubinstein M. An antiviral soluble form of the LDL receptor induced by interferon. Science 262 (1993) 250-253
21. Uze G., Lutfalla G., and Gresser I. Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA. Cell 60 (1990) 225-234
22. Novick D., Cohen B., and Rubinstein M. The human interferon alpha/beta receptor: characterization and molecular cloning. Cell 77 (1994) 391-400
23. Cohen B., Novick D., Barak S., and Rubinstein M. Ligand-induced association of the type I interferon receptor components. Mol Cell Biol 15 (1995) 4208-4214